Clinical Trial UCI-17-48 Click to view printable page


HERO: A Multinational Phase 3, Randomized, Open-label, Parallelgroup Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

Principal Investigator

Edward Uchio


Learn More

For information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email

If you would like more information regarding this specific trial, please leave your name, phone number, and email. We will contact you promptly.

Name: Email: Phone: